177 related articles for article (PubMed ID: 17619134)
1. Antigenic characterisation of yeast-expressed lyssavirus nucleoproteins.
Kucinskaite I; Juozapaitis M; Serva A; Zvirbliene A; Johnson N; Staniulis J; Fooks AR; Müller T; Sasnauskas K; Ulrich RG
Virus Genes; 2007 Dec; 35(3):521-9. PubMed ID: 17619134
[TBL] [Abstract][Full Text] [Related]
2. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains.
Malerczyk C; Selhorst T; Tordo N; Moore S; Müller T
Vaccine; 2009 Aug; 27(39):5320-5. PubMed ID: 19615958
[TBL] [Abstract][Full Text] [Related]
3. Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis.
Genz B; Nolden T; Negatsch A; Teifke JP; Conzelmann KK; Finke S
Berl Munch Tierarztl Wochenschr; 2012; 125(5-6):219-27. PubMed ID: 22712419
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of bat lyssaviruses in Europe.
McElhinney LM; Marston DA; Leech S; Freuling CM; van der Poel WH; Echevarria J; Vázquez-Moron S; Horton DL; Müller T; Fooks AR
Zoonoses Public Health; 2013 Feb; 60(1):35-45. PubMed ID: 22937876
[TBL] [Abstract][Full Text] [Related]
5. Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein.
Marston DA; McElhinney LM; Banyard AC; Horton DL; Núñez A; Koser ML; Schnell MJ; Fooks AR
J Gen Virol; 2013 Feb; 94(Pt 2):284-292. PubMed ID: 23100360
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the complete genome of the first Irkut virus isolate from China: comparison across the Lyssavirus genus.
Liu Y; Li N; Zhang S; Zhang F; Lian H; Wang Y; Zhang J; Hu R
Mol Phylogenet Evol; 2013 Dec; 69(3):687-93. PubMed ID: 23872529
[TBL] [Abstract][Full Text] [Related]
7. Generation of recombinant European bat lyssavirus type 1 and inter-genotypic compatibility of lyssavirus genotype 1 and 5 antigenome promoters.
Orbanz J; Finke S
Arch Virol; 2010 Oct; 155(10):1631-41. PubMed ID: 20614145
[TBL] [Abstract][Full Text] [Related]
8. Lyssavirus infection: 'low dose, multiple exposure' in the mouse model.
Banyard AC; Healy DM; Brookes SM; Voller K; Hicks DJ; Núñez A; Fooks AR
Virus Res; 2014 Mar; 181():35-42. PubMed ID: 24380842
[TBL] [Abstract][Full Text] [Related]
9. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary trends of European bat lyssavirus type 2 including genetic characterization of Finnish strains of human and bat origin 24 years apart.
Jakava-Viljanen M; Nokireki T; Sironen T; Vapalahti O; Sihvonen L; Huovilainen A
Arch Virol; 2015 Jun; 160(6):1489-98. PubMed ID: 25877913
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
[TBL] [Abstract][Full Text] [Related]
12. Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.
Wright E; Temperton NJ; Marston DA; McElhinney LM; Fooks AR; Weiss RA
J Gen Virol; 2008 Sep; 89(Pt 9):2204-2213. PubMed ID: 18753230
[TBL] [Abstract][Full Text] [Related]
13. Antigenic characterisation of lyssaviruses in South Africa.
Ngoepe E; Fehlner-Gardiner C; Wandeler A; Sabeta C
Onderstepoort J Vet Res; 2014 Sep; 81(1):. PubMed ID: 25685866
[TBL] [Abstract][Full Text] [Related]
14. The Lyssavirus glycoprotein: A key to cross-immunity.
Buthelezi SG; Dirr HW; Chakauya E; Chikwamba R; Martens L; Tsekoa TL; Stoychev SH; Vandermarliere E
Virology; 2016 Nov; 498():250-256. PubMed ID: 27614701
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region.
Marston DA; McElhinney LM; Johnson N; Müller T; Conzelmann KK; Tordo N; Fooks AR
J Gen Virol; 2007 Apr; 88(Pt 4):1302-1314. PubMed ID: 17374776
[TBL] [Abstract][Full Text] [Related]
16. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
Müller T; Selhorst T; Burow J; Schameitat A; Vos A
Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
[TBL] [Abstract][Full Text] [Related]
17. Bat rabies surveillance in Europe.
Schatz J; Fooks AR; McElhinney L; Horton D; Echevarria J; Vázquez-Moron S; Kooi EA; Rasmussen TB; Müller T; Freuling CM
Zoonoses Public Health; 2013 Feb; 60(1):22-34. PubMed ID: 22963584
[TBL] [Abstract][Full Text] [Related]
18. Development of a hemi-nested RT-PCR method for the specific determination of European Bat Lyssavirus 1. Comparison with other rabies diagnostic methods.
Picard-Meyer E; Bruyère V; Barrat J; Tissot E; Barrat MJ; Cliquet F
Vaccine; 2004 May; 22(15-16):1921-9. PubMed ID: 15121304
[TBL] [Abstract][Full Text] [Related]
19. A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies.
Xu G; Weber P; Hu Q; Xue H; Audry L; Li C; Wu J; Bourhy H
Biologicals; 2007 Oct; 35(4):297-302. PubMed ID: 17276082
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a panel of anti-phosphoprotein monoclonal antibodies directed against Mokola virus.
Nadin-Davis SA; Elmgren L; Sheen M; Sabeta C; Wandeler AI
Virus Res; 2011 Sep; 160(1-2):238-45. PubMed ID: 21749906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
